11 Results for "

histone deacetylase 8

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "histone deacetylase 8" in MCE Product Catalog:

Cat. No.: HY-P83249
Synonyms: HDAC8; HDACL1; CDA07; histone deacetylase 8; HD8

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P83249A
Synonyms: HDAC8; HDACL1; CDA07; histone deacetylase 8; HD8

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-33451
CAS No.: 2786-05-2
Research Areas:  

Others

4-Dibenzofurancarboxylic acid is one of the synthesis materials of polycyclic aromatic hydrocarbons (PAHs) and Schistosoma mansoni histone deacetylase 8 (smHDAC8) inhibitors .
loading...
    loading...
Cat. No.: HY-144098
CAS No.: 2824131-20-4
Target:  

Parasite HDAC

Research Areas:  

Others

HDAC8-IN-2 (compound 5o) is a potent HDAC8 inhibitor, with IC50 values of 0.27 and 0.32 μM for smHDAC8 (Schistosoma mansoni histone deacetylase 8) and hHDAC8, respectively. HDAC8-IN-2 shows significant killing of the schistosome larvae. HDAC8-IN-2 markedly impairs egg laying of adult worm pairs .
loading...
    loading...
Cat. No.: HY-P702858
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HDAC8; RPD3; Prev. HDACL1; histone deacetylase-Like 1; Prev. MRXS6; Wilson-Turner X-Linked Mental Retardation Syndrome; Prev. WTS; histone deacetylase; Protein Decrotonylase HDAC8; CDA07; Protein deacetylase HDAC8; CDLS5; KDAC8; histone deacetylase 8; HD8
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-P75144
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HDAC8; RPD3; Prev. HDACL1; histone deacetylase-Like 1; Prev. MRXS6; Wilson-Turner X-Linked Mental Retardation Syndrome; Prev. WTS; histone deacetylase; Protein Decrotonylase HDAC8; CDA07; Protein deacetylase HDAC8; CDLS5; KDAC8; histone deacetylase 8; HD8
Species:  
Mouse
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-117093
CAS No.: 423731-10-6
Target:  

HDAC

Research Areas:  

Cancer

H8-A5 is a novel human histone deacetylase 8 (HDAC8) inhibitor. A highly specific ZBG-based pharmacophore model was developed by incorporating a custom zinc-binding group (ZBG) feature. Pharmacophore-based virtual screening identified three novel HDAC8 inhibitors with low micromolar IC50 values (1.8-1.9 μM). Further studies showed that H8-A5 was more selective for HDAC8 than HDAC1/4 and exhibited antiproliferative activity in MDA-MB-231 cancer cells. Molecular docking and molecular dynamics studies showed that H8-A5 could bind to HDAC8, providing a good starting point for the development of HDAC8 inhibitors for cancer treatment.
loading...
    loading...
Cat. No.: HY-P88012
Synonyms: HDACL1, CDA07, HDAC8, histone deacetylase 8, HD8, Protein deacetylase HDAC8, Protein decrotonylase HDAC8

Host:  

Rabbit

Application:  

WB, FC, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-111027
CAS No.: 949792-00-1
Target:  

Apoptosis

Research Areas:  

Infection

HDAC8-IN-13 is a novel histone deacetylase 8 (HDAC8) inhibitor with antiparasitic activity. HDAC8-IN-13 can effectively inhibit the acetyl-L-lysine deacetylase activity of schistosomes, affecting the parasite's infectivity. HDAC8-IN-13 can induce apoptosis and cause the death of schistosome cells. Through a specific structural basis design, HDAC8-IN-13 exhibits reduced affinity for human HDACs, thereby enhancing its selectivity .
loading...
    loading...
Cat. No.: HY-182035
CAS No.: 2464465-06-1
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC8-IN-16 is a selective histone deacetylase 8 (HDAC8) inhibitor with an IC50 of 0.16 μM. HDAC8-IN-16 induces cell apoptosis, triggers G2/M phase cell cycle arrest, and moderately inhibits cancer cell proliferation. HDAC8-IN-16 is applicable to relevant research on colorectal cancer .
loading...
    loading...
Cat. No.: HY-187382
Target:  

HDAC

Research Areas:  

Cancer

HDAC8-IN-17 is a histone deacetylase 8 inhibitor with human IC50 values of 0.08 μM, 0.44 μM, and 1.9 μM, and high selectivity over HDAC1, HDAC2, HDAC3, and HDAC6. HDAC8-IN-17 exhibits slow-binding, reversible uncompetitive inhibition via allosteric binding to the enzyme-substrate complex. HDAC8-IN-17 induces selective hyperacetylation of SMC3. HDAC8-IN-17 can be used for the research of cancer .
loading...
    loading...
  • 1